Position
Capital Analysts, LLC in Maxcyte, Inc.
Back to the book · All holders of MXCT
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$1$0.00 → $0.00
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 1.27K | $2 | — | — | — | 0.0% |
| Q1 2026 | 1.27K | $1 | $0.00 | −$1 | $0 | 0.0% |